<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>TidyMS preprocessing pipeline distinguishes diabetic plasma pool — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>TidyMS preprocessing pipeline</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>diabetic plasma pool</strong>
</div>
<div class="entity-id">UNKNOWN:tidyms preprocessing pipeline &nbsp;&middot;&nbsp; UNKNOWN:diabetic_plasma</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 74.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.0 (Physical) &times; log&#8322;(1+1) = 10.00<br>Incoming citations: 8 &rarr; score 74.00</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.3390/metabo10100416">10.3390/metabo10100416</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS1919">MTBLS1919</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 8 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:25px"></span><span>1</span><span class="cite-subtotal">&middot; +8.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">nephrectomy — treats → clear cell renal cell carcinoma</span><span class="cite-claim-weight">+8.00</span><a href="../claim/b0f42aee6dd65eb7.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>4</span><span class="cite-subtotal">&middot; +48.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">16-lipid panel — distinguishes → clear cell renal cell carcinoma</span><span class="cite-claim-weight">+12.00</span><a href="../claim/051ad04da92fc083.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">16-lipid panel — predicts → metabolic phenoreversion after nephrectomy</span><span class="cite-claim-weight">+12.00</span><a href="../claim/073c659a6fe48dbf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PC 16:0/0:0 — distinguishes → clear cell renal cell carcinoma poor prognosis vs improved outcome</span><span class="cite-claim-weight">+12.00</span><a href="../claim/3778f38cfac4103a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PC 18:2/18:2 — distinguishes → clear cell renal cell carcinoma poor prognosis vs improved outcome</span><span class="cite-claim-weight">+12.00</span><a href="../claim/452456ab0a72383d.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:75px"></span><span>3</span><span class="cite-subtotal">&middot; +18.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">linoleic acid — distinguishes → clear cell renal cell carcinoma poor prognosis vs improved outcome</span><span class="cite-claim-weight">+6.00</span><a href="../claim/92cace5c27c4b489.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PC 16:0/0:0 / linoleic acid ratio — predicts → clear cell renal cell carcinoma prognosis</span><span class="cite-claim-weight">+6.00</span><a href="../claim/a439d67fe184f385.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PC 18:2/18:2 / linoleic acid ratio — predicts → clear cell renal cell carcinoma prognosis</span><span class="cite-claim-weight">+6.00</span><a href="../claim/d7b14bc931d41ac9.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>5d4cf5eb56448375</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:tidyms preprocessing pipeline">UNKNOWN:tidyms preprocessing pipeline</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:diabetic_plasma">UNKNOWN:diabetic_plasma</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
